Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-19

Clinical Trial Update: The Role of CALLY and HAALP in Ulcerative Colitis

View source ↗

Summary

A clinical trial from Ataturk University evaluating CALLY and HAALP for Ulcerative Colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CALLY
  • HAALP

Snippet

Sponsor: Ataturk University | Conditions: Ulcerative Colitis (UC) | Status: COMPLETED